Edding Genor Group Holdings Limited
Status: Publicly traded
Direct answer
Edding Genor Group Holdings Limited is publicly traded on HKSE under the ticker 6998.HK.
Genor Biopharma Holdings Limited operates as a biopharmaceutical enterprise, concentrating its efforts on the research, development, and commercialization of therapeutic agents for oncology and autoimmune disorders, both within China and globally. Its key investigational medicines include GB242, an infliximab (Remicade) biosimilar. This drug is purposed for the treatment of various conditions such as rheumatoid...
Can you invest in Edding Genor Group Holdings Limited?
Yes. Edding Genor Group Holdings Limited trades publicly on HKSE as 6998.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Edding Genor Group Holdings Limited
Detailed equity research is provided by MarketSnap.